RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$66.39M	-
CEO	Shah Gaurav	778.3K	$2.69M	-
COO	Stevens Christopher James	407.2K	$1.41M	-
Other	Wilson Martin	383.8K	$1.33M	-
Other	Schwartz Jonathan David	299.1K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 17, 2023	Patel Kinnari69	See Remarks	Sell	1,330	$21.38	$28,428.75	-0.6%	-24.7%	+8.5%
May 17, 2023	Militello John72	See Remarks	Sell	245	$21.38	$5,236.88	-3.9%	-24.7%	+8.5%
Apr 21, 2023	Militello John72	See Remarks	Sell	2,342	$18.65	$43,678.30	-29.4%	-0.6%	+23.1%
Feb 17, 2023	Schwartz Jonathan David72	See Remarks	Sell	3,557	$19.06	$67,796.42	-3.6%	+9.2%	+54.0%
Feb 17, 2023	Militello John72	See Remarks	Sell	1,244	$19.06	$23,710.64	-43.5%	+9.2%	+54.0%
Feb 17, 2023	Shah Gaurav71	CEO	Sell	12,194	$19.06	$232,417.64	-2.2%	+9.2%	+54.0%
Oct 6, 2022	Rtw Investments, LP63	Director, 10% Owner, See Remarks	Buy	1,355,932	$14.75	$19,999,997.00	+8.3%	+8.3%	+5.5%
Mar 30, 2022	Schwartz Jonathan David72	See Remarks	Sell	45,000	$16.41	$738,651.56	-10.3%	-19.3%	+2.1%
Feb 7, 2022	Shah Gaurav71	CEO	Buy	22,000	$17.34	$381,513.00	+4.4%	-52.7%	+20.2%
Jun 17, 2021	Makker Gotham72	Director	Sell	35,085	$46.85	$1,643,693.10	-1.3%	-23.0%	-75.0%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC